{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:54:54Z","timestamp":1793066094346,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2011-27910"],"award-info":[{"award-number":["SAF2011-27910"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-87595-R"],"award-info":[{"award-number":["SAF2017-87595-R"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2011-27910"],"award-info":[{"award-number":["SAF2011-27910"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Ministry of Economy and Competitiveness | Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF2017-87595-R"],"award-info":[{"award-number":["SAF2017-87595-R"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol."],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1038\/s41386-019-0503-8","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T20:02:21Z","timestamp":1567195341000},"page":"347-357","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Early sirtuin 2 inhibition prevents age-related cognitive decline in a senescence-accelerated mouse model"],"prefix":"10.1038","volume":"45","author":[{"given":"Teresa","family":"Diaz-Perdigon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco B.","family":"Belloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Ricobaraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elghareeb E.","family":"Elboray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2439-879X","authenticated-orcid":false,"given":"Takayoshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M.","family":"Tordera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5695-5787","authenticated-orcid":false,"given":"Elena","family":"Puerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"503_CR1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.tem.2014.08.003","volume":"25","author":"L Partridge","year":"2014","unstructured":"Partridge L. Intervening in ageing to prevent the diseases of ageing. Trends Endocrinol Metab 2014;25:555\u20137.","journal-title":"Trends Endocrinol Metab"},{"key":"503_CR2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1001\/jamaneurol.2013.1459","volume":"70","author":"S Akbarian","year":"2013","unstructured":"Akbarian S, Beeri MS, Haroutunian V. Epigenetic determinants of healthy and diseased brain aging and cognition. JAMA Neurol 2013;70:711\u20138.","journal-title":"JAMA Neurol"},{"key":"503_CR3","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/gerona\/glu042","volume":"69","author":"A Brunet","year":"2014","unstructured":"Brunet A, Berger SL. Epigenetics of aging and aging-related disease. J Gerontol Ser A Biol Sci Med Sci 2014;69:S17\u201320.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"issue":"6","key":"503_CR4","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/1567205016666190517121140","volume":"16","author":"Leonardo Guzman-Martinez","year":"2019","unstructured":"Guzman-Martinez L, Maccioni RB, Far\u00edas GA, Fuentes P, Navarrete LP. Biomarkers for Alzheimer\u2019s disease. Curr Alzheimer Res. 2019;16;518\u201328.","journal-title":"Current Alzheimer Research"},{"key":"503_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-011112-140216","volume":"53","author":"J Gr\u00e4ff","year":"2013","unstructured":"Gr\u00e4ff J, Tsai L-H. The potential of HDAC inhibitors as cognitive enhancers. Annu Rev Pharm Toxicol 2013;53:311\u201330.","journal-title":"Annu Rev Pharm Toxicol"},{"key":"503_CR6","volume":"5","author":"M Sharma","year":"2015","unstructured":"Sharma M, Shetty MS, Arumugam TV, Sajikumar S. Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B. Sci Rep 2015;5:16616.","journal-title":"Sci Rep"},{"key":"503_CR7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.neurobiolaging.2010.08.017","volume":"32","author":"D Mastroeni","year":"2011","unstructured":"Mastroeni D, et al. Epigenetic mechanisms in Alzheimer\u2019s disease. Neurobiol Aging 2011;32:1161\u201380.","journal-title":"Neurobiol Aging"},{"key":"503_CR8","doi-asserted-by":"crossref","DOI":"10.1038\/srep35391","volume":"6","author":"T Jayasena","year":"2016","unstructured":"Jayasena T, et al. Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system. Sci Rep 2016;6:35391.","journal-title":"Sci Rep"},{"key":"503_CR9","doi-asserted-by":"crossref","first-page":"1238858","DOI":"10.1126\/science.1238858","volume":"341","author":"HA Eskandarian","year":"2013","unstructured":"Eskandarian HA, et al. A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection. Science 2013;341:1238858.","journal-title":"Science"},{"key":"503_CR10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.neuroscience.2007.04.059","volume":"147","author":"K Suzuki","year":"2007","unstructured":"Suzuki K, Koike T. Mammalian Sir2-related protein (SIRT) 2\u2013mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation. Neuroscience 2007;147:599\u2013612.","journal-title":"Neuroscience"},{"key":"503_CR11","doi-asserted-by":"crossref","first-page":"e4090","DOI":"10.1371\/journal.pone.0004090","volume":"3","author":"JA Pfister","year":"2008","unstructured":"Pfister JA, Ma C, Morrison BE, D\u2019Mello SR. Opposing effects of sirtuins on neuronal survival: SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE 2008;3:e4090.","journal-title":"PLoS ONE"},{"key":"503_CR12","doi-asserted-by":"crossref","first-page":"3986","DOI":"10.1093\/hmg\/ddr326","volume":"20","author":"MM Maxwell","year":"2011","unstructured":"Maxwell MM, et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 2011;20:3986\u201396.","journal-title":"Hum Mol Genet"},{"key":"503_CR13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1080\/15384101.2016.1189041","volume":"15","author":"T Anwar","year":"2016","unstructured":"Anwar T, Khosla S, Ramakrishna G. Increased expression of SIRT2 is a novel marker of cellular senescence and is dependent on wild type p53 status. Cell Cycle 2016;15:1883\u201397.","journal-title":"Cell Cycle"},{"key":"503_CR14","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.1143780","volume":"317","author":"TF Outeiro","year":"2007","unstructured":"Outeiro TF, et al. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson\u2019s disease. Science 2007;317:516\u20139.","journal-title":"Science"},{"key":"503_CR15","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.celrep.2012.11.001","volume":"2","author":"V Chopra","year":"2012","unstructured":"Chopra V, et al. The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington\u2019s disease mouse models. Cell Rep 2012;2:1492\u20137.","journal-title":"Cell Rep"},{"key":"503_CR16","doi-asserted-by":"crossref","first-page":"e2000374","DOI":"10.1371\/journal.pbio.2000374","volume":"15","author":"RM de Oliveira","year":"2017","unstructured":"de Oliveira RM, et al. The mechanism of sirtuin 2\u2013mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease. PLoS Biol 2017;15:e2000374.","journal-title":"PLoS Biol"},{"key":"503_CR17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2017.01.033","volume":"117","author":"M Erburu","year":"2017","unstructured":"Erburu M, et al. SIRT2 inhibition modulate glutamate and serotonin systems in the prefrontal cortex and induces antidepressant-like action. Neuropharmacology 2017;117:195\u2013208.","journal-title":"Neuropharmacology"},{"key":"503_CR18","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbr.2017.07.045","volume":"335","author":"I Mu\u00f1oz-Cobo","year":"2017","unstructured":"Mu\u00f1oz-Cobo I, Belloch FB, D\u00edaz-Perdig\u00f3n T, Puerta E, Tordera RM. SIRT2 inhibition reverses anhedonia in the VGLUT1+\/- depression model. Behav Brain Res 2017;335:128\u201331.","journal-title":"Behav Brain Res"},{"key":"503_CR19","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jalz.2012.02.003","volume":"9","author":"L Polito","year":"2013","unstructured":"Polito L, et al. The SIRT2 polymorphism rs10410544 and risk of Alzheimer\u2019s disease in two Caucasian case-control cohorts. Alzheimers Dement 2013;9:392\u20139.","journal-title":"Alzheimers Dement"},{"key":"503_CR20","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s12017-014-8291-0","volume":"16","author":"W Wei","year":"2014","unstructured":"Wei W, et al. The SIRT2 polymorphism rs10410544 and risk of Alzheimer\u2019s disease: a meta-analysis. Neuromolecular Med 2014;16:448\u201356.","journal-title":"Neuromolecular Med"},{"key":"503_CR21","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/ijms20051249","volume":"20","author":"R Cacabelos","year":"2019","unstructured":"Cacabelos R, et al. Sirtuins in Alzheimer\u2019s disease: SIRT2-related genophenotypes and implications for pharmacoepigenetics. Int J Mol Sci 2019;20:1249.","journal-title":"Int J Mol Sci"},{"key":"503_CR22","first-page":"42","volume":"3","author":"TL Spires-Jones","year":"2012","unstructured":"Spires-Jones TL, et al. Inhibition of sirtuin 2 with sulfobenzoic acid derivative AK1 is non-toxic and potentially neuroprotective in a mouse model of frontotemporal dementia. Front Pharmacol 2012;3:42.","journal-title":"Front Pharmacol"},{"key":"503_CR23","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-151135","volume":"53","author":"G Biella","year":"2016","unstructured":"Biella G, et al. Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-\u03b2 protein precursor processing in two Alzheimer\u2019s disease mouse models. J Alzheimers Dis 2016;53:1193\u2013207.","journal-title":"J Alzheimers Dis"},{"key":"503_CR24","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1007\/s12035-016-9951-x","volume":"54","author":"DF Silva","year":"2017","unstructured":"Silva DF, Esteves AR, Oliveira CR, Cardoso SM. Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer\u2019s-disease related pathology. Mol Neurobiol 2017;54:4021\u201340.","journal-title":"Mol Neurobiol"},{"issue":"8","key":"503_CR25","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.bbadis.2018.11.014","volume":"1865","author":"A.R. Esteves","year":"2019","unstructured":"Esteves AR, et al. Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer\u2019s and Parkinson disease pathology. Biochim Biophys Acta. 2018. \nhttps:\/\/doi.org\/10.1016\/j.bbadis.2018.11.014\n\n.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"},{"key":"503_CR26","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s11064-009-9923-x","volume":"34","author":"K Tomobe","year":"2009","unstructured":"Tomobe K, Nomura Y. Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence. Neurochem Res 2009;34:660\u20139.","journal-title":"Neurochem Res"},{"key":"503_CR27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-2008-15408","volume":"15","author":"M Pallas","year":"2008","unstructured":"Pallas M, et al. From aging to Alzheimer\u2019s disease: unveiling \"the switch\" with the senescence-accelerated mouse model (SAMP8). J Alzheimers Dis 2008;15:615\u201324.","journal-title":"J Alzheimers Dis"},{"key":"503_CR28","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3233\/JAD-170664","volume":"62","author":"C Gri\u00f1\u00e1n-Ferr\u00e9","year":"2018","unstructured":"Gri\u00f1\u00e1n-Ferr\u00e9 C, et al. Understanding epigenetics in the neurodegeneration of Alzheimer\u2019s disease: SAMP8 mouse model. J Alzheimers Dis 2018;62:943\u201363.","journal-title":"J Alzheimers Dis"},{"key":"503_CR29","first-page":"51","volume":"6","author":"M Cos\u00edn-Tom\u00e1s","year":"2014","unstructured":"Cos\u00edn-Tom\u00e1s M, et al. Epigenetic alterations in hippocampus of SAMP8 senescent mice and modulation by voluntary physical exercise. Front Aging Neurosci 2014;6:51.","journal-title":"Front Aging Neurosci"},{"key":"503_CR30","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3389\/fgene.2018.00596","volume":"9","author":"M Cos\u00edn-Tom\u00e1s","year":"2018","unstructured":"Cos\u00edn-Tom\u00e1s M, et al. Temporal integrative analysis of mRNA and microRNAs expression profiles and epigenetic alterations in female SAMP8, a model of age-related cognitive decline. Front Genet 2018;9:596.","journal-title":"Front Genet"},{"key":"503_CR31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fnagi.2016.00241","volume":"8","author":"C Gri\u00f1an-Ferr\u00e9","year":"2016","unstructured":"Gri\u00f1an-Ferr\u00e9 C, et al. Environmental enrichment modified epigenetic mechanisms in SAMP8 mouse hippocampus by reducing oxidative stress and inflammaging and achieving neuroprotection. Front Aging Neurosci 2016;8:241.","journal-title":"Front Aging Neurosci"},{"key":"503_CR32","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s12035-015-9210-6","volume":"53","author":"C Gri\u00f1an-Ferr\u00e9","year":"2016","unstructured":"Gri\u00f1an-Ferr\u00e9 C, et al. Environmental enrichment improves behavior, cognition, and brain functional markers in young senescence-accelerated prone mice (SAMP8). Mol Neurobiol 2016;53:2435\u201350.","journal-title":"Mol Neurobiol"},{"key":"503_CR33","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1021\/jm3002108","volume":"55","author":"T Suzuki","year":"2012","unstructured":"Suzuki T, et al. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. J Med Chem 2012;55:5760\u201373.","journal-title":"J Med Chem"},{"key":"503_CR34","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0091-3057(94)00338-6","volume":"50","author":"JF Flood","year":"1995","unstructured":"Flood JF, Farr SA, Kaiser FE, Morley JE. Age-related impairment in learning but not memory in SAMP8 female mice. Pharm Biochem Behav 1995;50:661\u20134.","journal-title":"Pharm Biochem Behav"},{"key":"503_CR35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.exger.2013.03.001","volume":"48","author":"L Orejana","year":"2013","unstructured":"Orejana L, Barros-Mi\u00f1ones L, Aguirre N, Puerta E. Implication of JNK pathway on tau pathology and cognitive decline in a senescence-accelerated mouse model. Exp Gerontol 2013;48:565\u201371.","journal-title":"Exp Gerontol"},{"key":"503_CR36","doi-asserted-by":"crossref","first-page":"625.e11","DOI":"10.1016\/j.neurobiolaging.2011.03.018","volume":"33","author":"L Orejana","year":"2012","unstructured":"Orejana L, Barros-Mi\u00f1ones L, Jord\u00e1n J, Puerta E, Aguirre N. Sildenafil ameliorates cognitive deficits and tau pathology in a senescence-accelerated mouse model. Neurobiol Aging 2012;33:625.e11\u201320.","journal-title":"Neurobiol Aging"},{"key":"503_CR37","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/gerona\/glu106","volume":"70","author":"L Orejana","year":"2015","unstructured":"Orejana L, et al. Sildenafil decreases BACE1 and cathepsin B levels and reduces APP amyloidogenic processing in the SAMP8 mouse. J Gerontol Ser A Biol Sci Med Sci 2015;70:675\u201385.","journal-title":"J Gerontol Ser A Biol Sci Med Sci"},{"key":"503_CR38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-2627-5_5","volume":"1303","author":"A Garc\u00eda-Osta","year":"2016","unstructured":"Garc\u00eda-Osta A, Cuadrado-Tejedor M. Advanced assay monitoring APP-carboxyl-terminal fragments as markers of APP processing in Alzheimer disease mouse models. Methods Mol Biol 2016;1303:117\u201323.","journal-title":"Methods Mol Biol"},{"key":"503_CR39","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.neuint.2012.07.010","volume":"61","author":"J Gal","year":"2012","unstructured":"Gal J, Bang Y, Choi HJ. SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition. Neurochem Int 2012;61:992\u20131000.","journal-title":"Neurochem Int"},{"key":"503_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2008.03.015","volume":"58","author":"L Gan","year":"2008","unstructured":"Gan L, Mucke L. Paths of convergence: sirtuins in aging and neurodegeneration. Neuron 2008;58:10\u201314.","journal-title":"Neuron"},{"key":"503_CR41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/1567205015666181109103742","volume":"16","author":"P Wongchitrat","year":"2018","unstructured":"Wongchitrat P, et al. Alterations in the expression of amyloid precursor protein cleaving enzymes mRNA in Alzheimer peripheral blood. Curr Alzheimer Res 2018;16:29\u201338.","journal-title":"Curr Alzheimer Res"},{"key":"503_CR42","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.3390\/ijms18102207","volume":"18","author":"D Wloga","year":"2017","unstructured":"Wloga D, Joachimiak E, Fabczak H. Tubulin post-translational modifications and microtubule dynamics. Int J Mol Sci 2017;18:2207.","journal-title":"Int J Mol Sci"},{"key":"503_CR43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1179\/1743132814Y.0000000416","volume":"37","author":"DY Yoo","year":"2015","unstructured":"Yoo DY, et al. Sodium butyrate, a histone deacetylase Inhibitor, ameliorates SIRT2-induced memory impairment, reduction of cell proliferation, and neuroblast differentiation in the dentate gyrus. Neurol Res 2015;37:69\u201376.","journal-title":"Neurol Res"},{"key":"503_CR44","doi-asserted-by":"crossref","first-page":"18303","DOI":"10.1073\/pnas.1314145110","volume":"110","author":"V Theendakara","year":"2013","unstructured":"Theendakara V, et al. Neuroprotective Sirtuin ratio reversed by ApoE4. Proc Natl Acad Sci USA 2013;110:18303\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"503_CR45","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1007\/s11357-012-9489-4","volume":"35","author":"D Porquet","year":"2013","unstructured":"Porquet D, et al. Dietary resveratrol prevents Alzheimer\u2019s markers and increases life span in SAMP8. Age (Dordr) 2013;35:1851\u201365.","journal-title":"Age (Dordr)"},{"key":"503_CR46","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ncb2069","volume":"12","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, et al. Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity. Nat Cell Biol 2010;12:665\u201375.","journal-title":"Nat Cell Biol"},{"key":"503_CR47","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1111\/febs.12810","volume":"281","author":"T Inoue","year":"2014","unstructured":"Inoue T, et al. SIRT2 knockdown increases basal autophagy and prevents postslippage death by abnormally prolonging the mitotic arrest that is induced by microtubule inhibitors. FEBS J 2014;281:2623\u201337.","journal-title":"FEBS J"},{"key":"503_CR48","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.nlm.2016.07.002","volume":"133","author":"R Fonseca","year":"2016","unstructured":"Fonseca R. The aging memory: modulating epigenetic modifications to improve cognitive function. Neurobiol Learn Mem 2016;133:182\u20134.","journal-title":"Neurobiol Learn Mem"},{"key":"503_CR49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharm Rev 2010;62:405\u201396.","journal-title":"Pharm Rev"},{"key":"503_CR50","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0169-328X(01)00344-8","volume":"99","author":"KR Magnusson","year":"2002","unstructured":"Magnusson KR, Nelson SE, Young AB. Age-related changes in the protein expression of subunits of the NMDA receptor. Brain Res Mol Brain Res 2002;99:40\u201345.","journal-title":"Brain Res Mol Brain Res"},{"key":"503_CR51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.bbr.2012.10.026","volume":"238","author":"BL Brim","year":"2013","unstructured":"Brim BL, et al. Memory in aged mice is rescued by enhanced expression of the GluN2B subunit of the NMDA receptor. Behav Brain Res 2013;238:211\u201326.","journal-title":"Behav Brain Res"},{"key":"503_CR52","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1007\/s00213-018-4975-8","volume":"235","author":"I Mu\u00f1oz-Cobo","year":"2018","unstructured":"Mu\u00f1oz-Cobo I, et al. Nucleocytoplasmic export of HDAC5 and SIRT2 downregulation: two epigenetic mechanisms by which antidepressants enhance synaptic plasticity markers. Psychopharmacology (Berl) 2018;235:2831\u201346.","journal-title":"Psychopharmacology (Berl)"},{"key":"503_CR53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/acel.12282","volume":"14","author":"Y Luo","year":"2015","unstructured":"Luo Y, et al. Reversal of aging-related emotional memory deficits by norepinephrine via regulating the stability of surface AMPA receptors. Aging Cell 2015;14:170\u20139.","journal-title":"Aging Cell"},{"key":"503_CR54","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1007\/s11064-016-1981-2","volume":"41","author":"B Wang","year":"2016","unstructured":"Wang B, et al. SIRT2 plays significant roles in lipopolysaccharides-induced neuroinflammation and brain injury in mice. Neurochem Res 2016;41:2490\u20132500.","journal-title":"Neurochem Res"},{"key":"503_CR55","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2016.11.061","volume":"517","author":"LCGEI Moreno","year":"2017","unstructured":"Moreno LCGEI, et al. Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int J Pharm 2017;517:50\u201357.","journal-title":"Int J Pharm"},{"key":"503_CR56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jnutbio.2017.07.011","volume":"49","author":"L Ranc\u00e1n","year":"2017","unstructured":"Ranc\u00e1n L, et al. Protective effect of xanthohumol against age-related brain damage. J Nutr Biochem 2017;49:133\u201340.","journal-title":"J Nutr Biochem"},{"key":"503_CR57","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2174\/1567205014666170207093455","volume":"14","author":"J Cheng","year":"2017","unstructured":"Cheng J, et al. Vitamin D combined with resveratrol prevents cognitive decline in SAMP8 mice. Curr Alzheimer Res 2017;14:820\u201333.","journal-title":"Curr Alzheimer Res"},{"key":"503_CR58","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.pbb.2013.02.002","volume":"105","author":"CY Sun","year":"2013","unstructured":"Sun CY, et al. Neurobiological and pharmacological validity of curcumin in ameliorating memory performance of senescence-accelerated mice. Pharm Biochem Behav 2013;105:76\u201382.","journal-title":"Pharm Biochem Behav"},{"key":"503_CR59","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3390\/molecules23010196","volume":"23","author":"Z-J Chen","year":"2018","unstructured":"Chen Z-J, Yang Y-F, Zhang Y-T, Yang D-H. Dietary total prenylflavonoids from the fruits of Psoralea corylifolia L. prevents age-related cognitive deficits and down-regulates Alzheimer\u2019s markers in SAMP8 mice. Molecules 2018;23:196.","journal-title":"Molecules"},{"key":"503_CR60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphar.2014.00089","volume":"5","author":"C Scuderi","year":"2014","unstructured":"Scuderi C, et al. Sirtuin modulators control reactive gliosis in an in vitro model of Alzheimer\u2019s disease. Front Pharmacol 2014;5:89.","journal-title":"Front Pharmacol"},{"key":"503_CR61","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.bbrc.2014.06.135","volume":"450","author":"AS Lee","year":"2014","unstructured":"Lee AS, et al. SIRT2 ameliorates lipopolysaccharide-induced inflammation in macrophages. Biochem Biophys Res Commun 2014;450:1363\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"503_CR62","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/WNR.0000000000000305","volume":"26","author":"H Chen","year":"2015","unstructured":"Chen H, Wu D, Ding X, Ying W. SIRT2 is required for lipopolysaccharide-induced activation of BV2 microglia. Neuroreport 2015;26:88\u201393.","journal-title":"Neuroreport"},{"key":"503_CR63","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/156652401507150903185852","volume":"15","author":"T Zhao","year":"2015","unstructured":"Zhao T, et al. Selective inhibition of SIRT2 improves outcomes in a lethal septic model. Curr Mol Med 2015;15:634\u201341.","journal-title":"Curr Mol Med"},{"key":"503_CR64","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1038\/emboj.2013.200","volume":"32","author":"TF Pais","year":"2013","unstructured":"Pais TF, et al. The NAD-dependent deacetylase sirtuin 2 is a suppressor of microglial activation and brain inflammation. EMBO J 2013;32:2603\u201316.","journal-title":"EMBO J"},{"key":"503_CR65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/jnc.13423","volume":"136","author":"F Yuan","year":"2016","unstructured":"Yuan F, et al. SIRT2 inhibition exacerbates neuroinflammation and blood-brain barrier disruption in experimental traumatic brain injury by enhancing NF-\u03baB p65 acetylation and activation. J Neurochem 2016;136:581\u201393.","journal-title":"J Neurochem"},{"key":"503_CR66","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2443.2010.01460.x","volume":"16","author":"Y Li","year":"2011","unstructured":"Li Y, et al. SIRT2 down-regulation in HeLa can induce p53 accumulation via p38 MAPK activation-dependent p300 decrease, eventually leading to apoptosis. Genes Cells 2011;16:34\u201345.","journal-title":"Genes Cells"},{"key":"503_CR67","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbrc.2011.11.141","volume":"417","author":"X He","year":"2012","unstructured":"He X, et al. SIRT2 activity is required for the survival of C6 glioma cells. Biochem Biophys Res Commun 2012;417:468\u201372.","journal-title":"Biochem Biophys Res Commun"},{"key":"503_CR68","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.febslet.2008.07.016","volume":"582","author":"EG Lynn","year":"2008","unstructured":"Lynn EG, McLeod CJ, Gordon JP, Bao J, Sack MN. SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells. FEBS Lett 2008;582:2857\u201362.","journal-title":"FEBS Lett"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0503-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41386-019-0503-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:07:11Z","timestamp":1684616831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41386-019-0503-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1038\/s41386-019-0503-8","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"6 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}